LIORESAL

Main information

  • Trade name:
  • LIORESAL 25 mg tablet
  • Dosage:
  • 25 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LIORESAL 25 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Baclofen
  • Product summary:
  • Suitability for use in older adult patients Baclofenum Avoid using for elderly persons. Slightly anticholinergic. Slightly sedative. Reduce the dose in even mild renal insufficiency. Significant adverse effects include tiredness, confusion, depression, nightmares, muscular weakness, hypotension and risk for falls. May potentiate the sedative effects of other simultaneously used drugs affecting the CNS.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 6385
  • Authorization date:
  • 13-02-2009
  • Last update:
  • 26-07-2018